Digital NanoGenetics is developing novel nanofluidics with applications in molecular biology, sensor technology and clinical chemistry. The firm's primary focus has been on the development of a single molecule sequencing technology capable of producing the lowest cost, highest accuracy and fastest human genome with a read length of over 40,000 for the distributed clinical marketplace.
